Stress-Induced Metabolic Disorders: Mechanisms, Pathologies, and Prospects

1. Introduction

The detrimental effects of stress on both emotional and physical health [1] are well-documented and increasingly recognized as significant public health concerns. Occupational stress, in particular, represents the predominant source of chronic stress globally and has steadily intensified over recent decades [2]. Elevated levels of job-related stress, characterized by high demands and a perceived lack of control, have been consistently associated with heightened risks of cardiovascular events (e.g., myocardial infarction, hypertension), metabolic disorders (e.g., obesity), substance use disorders, anxiety, depression, and other mental and physical health conditions [3]. According to Gallup's State of the Global Workplace 2023 report, 41% of global employees and 52% of US of those in East Asia reported experiencing significant stress the preceding day, underscoring the widespread prevalence of this issue (https://www.gallup.com/workplace/349484/state-of-the-global-workplace.aspx).

Among the various health consequences, stress-induced metabolic disorders have emerged as a critical area of concern. These disorders result from the interplay of physiological, behavioral, and molecular mechanisms. Stress is fundamentally a state of threatened homeostasis that elicits adaptive physiological responses, centrally regulated by the brain. The neuroendocrine systems of the hypothalamic-pituitary-adrenal (HPA) axis [4] and the sympathetic nervous system (SNS) play a central role in mediating these responses [5]. The key stress hormones cortisol and catecholamines (e.g., adrenaline and noradrenaline) are essential for short-term adaptation to stress. However, chronic activation of these systems can override their protective functions. Sustained elevations in cortisol and catecholamines contribute to systemic dysregulation and are implicated in the pathogenesis of a range of health conditions, including metabolic syndrome [6], obesity [7], cancer [8], mental health disorders [9], hyperuricemia [10], cardiovascular disease [11], and increased susceptibility to infections [12].

Stress-induced metabolic disorders result from a complex interplay of hormonal dysregulation, chronic inflammation, behavioral changes, molecular disturbances, and structural alterations at the cellular level, such as those affecting caveolae. These interconnected mechanisms create a self-perpetuating cycle that progressively impairs metabolic health. Understanding the biological pathways that link chronic stress to metabolic dysfunction is therefore essential.

Given the widespread prevalence of both chronic stress and metabolic diseases in modern society, their potential pathophysiological interaction represents a significant public health concern. Effective prevention and management require a comprehensive approach that includes stress reduction, nutritional interventions, and regular physical activity.

This review aims to examine the key mechanisms underlying the relationship between chronic stress and metabolic disorders, with a particular focus on metabolic syndrome and hyperuricemia.

2. Mechanisms Underlying Stress-Induced Metabolic Disorders

Chronic psychological stress disrupts metabolic balance through neuroendocrine, immune, and behavioral mechanisms [13,14]. Persistent activation of the HPA axis elevates cortisol, leading to insulin resistance, abdominal obesity, and other metabolic syndrome features. Glucocorticoids (GCs) and the catecholamines act synergistically to raise blood glucose levels [15] as does the catecholamine-induced increase in cardiovascular output [16]. Concurrent stimulation of the SNS raises catecholamine levels, further impairing metabolism and promoting inflammation. Behavioral changes such as poor diet, inactivity, and inadequate sleep exacerbate these effects. On a cellular level, stress-related hormones and cytokines hinder insulin signaling, damage mitochondria, and elevate oxidative stress [17]. These processes contribute to metabolic disorders, including hyperuricemia, highlighting the complex and multifactorial nature of stress-induced metabolic dysfunction.

2.1. Hormonal Imbalances via HPA Axis and SNS Activation

Chronic stress activates the HPA axis, leading to sustained cortisol secretion. Cortisol promotes gluconeogenesis and lipolysis, increasing blood glucose and free fatty acids. Over time, this contributes to insulin resistance and hyperglycemia [18], and hypertension [19],  hallmarks of metabolic syndrome. Cortisol may also be associated with elevated uric acid level under physical stress [20].

SNS activation releases catecholamines, which enhance lipolysis and gluconeogenesis [21], and mobilize glucose and fatty acids, exacerbating oxidative stress and inflammation. Prolonged SNS activity elevates blood pressure and free fatty acids, exacerbating hypertension and insulin resistance [22], and hyperuricemia [23].

HPA activity promotes visceral fat storage, which is metabolically active and secretes pro-inflammatory cytokines [24]. This chronic low-grade inflammation impairs insulin signaling, linking obesity to insulin resistance and metabolic syndrome [25].

2.2. Glucocorticoid Resistance

Chronic stress contributes to metabolic dysfunction involving the development of GC resistance, which attenuates cortisol’s anti-inflammatory effects [26]. GCs redistribute fat to visceral depots, increasing cardiovascular risk [27]. This resistance allows inflammation to persist, particularly within visceral adipose tissue, where immune cells actively contribute to tissue damage, atherosclerosis, and insulin resistance. Inflammatory cytokines, such as TNF-α, IL-6, and CRP, further disrupt insulin receptor signaling, impairing glucose uptake [28] in the liver and skeletal muscles. Concurrently, elevated gluconeogenesis and increased levels of free fatty acids exacerbate hepatic insulin resistance and contribute to the development of non-alcoholic fatty liver disease (NAFLD) [29]. Persistent insulin resistance places chronic demand on pancreatic β-cells, which may ultimately lead to β-cell exhaustion and the progression of type 2 diabetes. Additionally, chronic stress increases the production of reactive oxygen species (ROS) [30], causing mitochondrial damage and further impairing insulin signaling pathways [31]. Together, these stress-induced inflammatory and oxidative processes play a central role in the pathogenesis of insulin resistance and related metabolic disorders.

2.3. Behavioral and Lifestyle Factors

Beyond hormonal dysregulation, stress significantly influences behavioral patterns that contribute to metabolic disorders. Stress-induced comfort eating leads to increased consumption of high-calorie, sugar- and fat-rich foods, a behaviour mediated through hypothalamic reward pathways [32] and associated with weight gain. Additionally, stress-related sleep disturbances disrupt the balance of leptin (a satiety hormone) and ghrelin (a hunger hormone), enhancing appetite and food cravings [33]. Reduced physical activity due to stress exacerbates energy imbalance [34], accelerating obesity and metabolic complications.

2.4. Gut Dysbiosis

Stress disrupts gut microbiota dysbiosis [35], increasing intestinal permeability and disrupting uric acid metabolism [36]. This allows endotoxins into the bloodstream, leading to metabolic endotoxemia [37], which drives inflammation, insulin resistance and hyperuricemia [38].

2.5. Epigenetic Changes

Chronic stress may induce epigenetic changes (e.g., DNA methylation) in genes regulating glucose/lipid metabolism [39], predisposing individuals to metabolic diseases.

2.6. Oxidative Stress and Mitochondrial Dysfunction

Chronic stress amplifies oxidative stress, contributing to mitochondrial dysfunction and impaired insulin signaling.  Stress-induced TNF-α, IL-6, and CRP promote insulin resistance and endothelial dysfunction [40]. Oxidative stress from prolonged cortisol exposure damages mitochondria, impairing energy metabolism [41].

2.7. Caveolar Dysfunction

Psychological stress exerts its effects indirectly but meaningfully, on caveolar function through systemic pathways. Caveolae are small plasma membrane invaginations that serve as critical platforms for cellular adaptation to various stressors [42]. Their structure and function are deeply influenced by mechanical, oxidative, and metabolic stress, with widespread implications for metabolic diseases [43]. Caveolae are critical regulators of cellular responses to stress. Dysfunction of caveolae is linked to a range of diseases, including cardiovascular disorders, metabolic syndrome, and hyperuricemia and highlighting their potential as therapeutic targets for enhancing cellular resilience [38,44].

Mechanical Stress induces caveolae formation [45]. Caveolae flatten in response to membrane tension, acting as protective buffers against mechanical damage [46]. This mechanoprotective function buffers cells against rupture and damage. It relies on the caveolin-1 (Cav1) protein for maintaining caveolar structure. Deficiency or dysfunction in caveolae increases susceptibility to diseases like muscular dystrophy, pulmonary fibrosis, and atherosclerosis [47].

Caveolae compartmentalize key components of redox signaling by localizing ROS-producing enzymes and antioxidant systems, maintaining redox homeostasis [48] . They also regulate key signaling pathways (e.g., MAPK, AKT) involved in cell survival and apoptosis. Disruption of these roles contributes to oxidative stress and metabolic dysfunction [49] .

Caveolae are central to lipid, eNOS, uric acid  and glucose metabolism [50,51]. They facilitate cholesterol uptake, insulin receptor organization, and glucose or uric acid transporter function. Metabolic stressors, resulting from excess of nutrients such as hyperlipidaemia and diabetes, impair these processes, promoting insulin resistance and metabolic syndrome [43]. Caveolae can help endothelial cells adapt to shear stress from blood flow, and loss caveolae can disrupt vascular tone and promotes hypertension [52].

Overall, caveolae serve as crucial integrators of stress signals. Their dysfunction under chronic stress conditions plays a significant role in the development of metabolic syndrome, cardiovascular disease, hypertension, and hyperuricemia [43,51] .

3. Clinical Manifestations of Metabolic Diseases under Chronic Stress

Chronic stress is a risk factor for the development of metabolic diseases. Meta-analysis links anxiety/stress to 7–14% increased risk of metabolic syndrone [53]. Chronic stress disrupts energy homeostasis, contributing to the development of metabolic diseases and can exacerbate existing conditions, making them harder to manage. Patients under chronic stress might have poorer outcomes, and managing stress could be part of treatment plans. Furthermore, the interplay between psychological factors and physiological changes, such as poor sleep and diet, and sedentary lifestyle, crease additional risk factors for metabolic disorders. Inflammation can link stress with metabolic diseases.  These interconnected mechanisms culminate in disruptions to glucose metabolism, visceral adiposity, inflammation, and behaviors that worsen metabolic health. The cluster of conditions, including insulin resistance, obesity, and dyslipidemia, resulting from systemic dysregulation may also interact synergistic effects to influence the body's response to stress. 

3.1. Hyperglycemia and diabetes

The effects of stress on type I diabetes remain contradictory. Some retrospective human studies suggest that psychological stress may precipitate type I diabetes as various stressors can either trigger or prevent the onset of experimental diabetes animal models [54]. Chronic stress impairs GLUT4 translocation and promotes hepatic gluconeogenesis [55], and reliably produces hyperglycemia which induced type II diabetes. At the cellular level, both environmental and internal stressors contribute to insulin resistance and β-cell dysfunction. These stressors activate molecular pathways that intensify endoplasmic reticulum (ER) stress, the integrated stress response, oxidative stress, and impair autophagy [56]. Although these stress-responsive pathways are interconnected, their individual roles in maintaining glucose homeostasis and preserving β-cell function are still under investigation [57].

Hyperinsulinism itself can cause elevated ER luminal hydrogen peroxide (H₂O₂) production, leading to mild ER stress and reduced cell viability, although additional damaging factors beyond H₂O₂ contribute to β-cell dysfunction [58]. Other stress induced disrupted pathologies can drive diabetes progression include dysregulated lipid signaling, mitochondrial oxidative stress, ER stress, and localized inflammation [59]. GCs and catecholamines are the primary hormonal mediators of the stress response. Although they do not typically cause adverse effects in the acute phase, prolonged exposure can disrupt glucose homeostasis, contributing to chronic hyperglycemia, insulin resistance, and the eventual development of type II diabetes [60].

In skeletal muscle, GCs inhibit the insulin-induced translocation of GLUT4 to the cell membrane, reducing glucose uptake and increasing blood glucose levels [61]. In white adipose tissue, GCs promote lipolysis, generating glycerol (a gluconeogenic substrate) and leading to the accumulation of nonesterified fatty acids in muscle cells [62]. These fatty acids impair insulin signaling, further diminishing glucose uptake and perpetuating a hyperglycemic state. Additionally, corticosteroids inhibit pancreatic β-cells from producing and secreting insulin [63].

Interestingly, acute hyperglycemia during stress may serve as an adaptive mechanism. It provides readily available energy to the brain and immune system during injury, infection, or stress, functioning as part of an evolutionary survival response [64]. However, when stress becomes chronic, persistent hyperglycemia contributes to insulin resistance and eventually type II diabetes. Additionally, diabetes may also cause abnormalities in the regulation of these stress hormones [29].

3.2. Obesity

Stress and obesity are two increasingly common health issues that are intricately connected through multiple pathways. Firstly, stress can impair decision-making related to food choices and lifestyle habits [65]. Secondly, stress promotes behavior by promoting overeating, particularly of high-calorie, high-fat, and high-sugar foods, while simultaneously reducing physical activity and shortening sleep duration, all of which contribute to weight gain [66,67].

On a physiological level, stress activates the HPA axis and alters reward processing in the brain [68]. It may also influence the gut microbiome [69], further impacting metabolic health. Additionally, stress stimulates the release of hormones and peptides including leptin, ghrelin, and neuropeptide Y [70,71], all of which play key roles in appetite regulation and energy balance.

Obesity itself can also become a source of chronic stress due to widespread weight stigma [72], exacerbating the cycle. Occupational stress has been linked to lipid disturbances through HPA axis dysregulation, influencing lipid intake and metabolism [73]. Chronic stress elevates cortisol levels, which in turn increases GC synthesis and glucose availability, promotes visceral fat accumulation, enhances lipolysis, and elevates circulating fatty acids, leading to dyslipidemia and contributing further to obesity [74].

3.3. Hypertension

Stress-induced hypertension refers to elevated blood pressure triggered or worsened by psychological or physical stress. Acute stress activates the SNS and the HPA axis, leading to the release of stress hormones such as adrenaline and cortisol. These hormones increase heart rate, constrict blood vessels, and raise blood pressure as part of the body's "fight or flight" response [75]. While this response is adaptive in short-term situations, chronic stress can result in persistent activation of these systems, leading to sustained hypertension [76]. Repeated exposure to stress may also contribute to unhealthy behaviors like poor diet, lack of exercise, smoking, and disrupted sleep, further increasing blood pressure. In addition, stress alters vascular tone, endothelial function, and kidney activity, all of which play important roles in blood pressure regulation. Stress-induced hypertension, dyslipidemia, and endothelial dysfunction accelerate atherosclerosis. Managing stress through lifestyle changes, relaxation techniques, regular physical activity, and psychological support is essential in preventing and controlling stress-related hypertension. β-blockers mitigate stress-driven vascular damage [77].

3.4. Hyperuricemia

Stress has been shown to induce hyperuricemia [78], a condition characterized by elevated levels of uric acid in the blood. Under restraint stress, there is a simultaneous increase in plasma uric acid levels and ROS generation, primarily due to xanthine oxidoreductase (XOR) activation in visceral adipose tissue (VAT), liver, and intestine. This stress-induced oxidative stress is further amplified by upregulation of NADPH oxidase (NOX) subunits and a reduction in antioxidant enzyme activities in VAT. In addition to oxidative stress, stress also triggers lipolysis and inflammation in adipose tissue, decreases insulin sensitivity, and promotes a prothrombotic state [79]. These changes contribute to a metabolic environment that favors the development of hyperuricemia and related complications.

Hyperuricemia has been shown to disrupt normal cortisol metabolism [80]. In this condition, the adrenal glands become less responsive to adrenocorticotropic hormone (ACTH), leading to reduced cortisol production, while corticosterone levels remain unaffected. This is linked to decreased mRNA expression of key cortisol-synthesizing enzymes, including aldosterone synthase, 11β-hydroxylase, and 3β-hydroxysteroid dehydrogenase 1 [81]. Additionally, the reduced expression of hepatic 5α-reductase and renal 11β-hydroxysteroid dehydrogenase 2 further impairs cortisol clearance. Together, these disturbances constitute a cortisol metabolism disorder associated with hyperuricemia [80].

3.5. Bidirectional Relationship

Metabolic disorders, the components of metabolic syndrome including obesity, type II diabetes mellitus, hypertension, and dyslipidemia, are intricately linked with both physiological and psychological stress [82]. These conditions are not only influenced by chronic stress but also act as significant contributors to stress-related pathologies, establishing a bidirectional, self-perpetuating cycle. Chronic emotional or occupational stress has been shown to increase the risk of developing metabolic syndrome [83,84]. In turn, the presence of metabolic dysfunctions can exacerbate stress responses by disrupting immune regulation and altering neurochemical pathways in the brain [85], thereby heightening stress sensitivity. Thus, stress serves both as a precursor to and a consequence of metabolic disease, reinforcing the complexity of their interrelationship.

Metabolic dysfunction disrupts the body’s internal balance, which activates the HPA axis, raising cortisol levels [86] that further aggravate metabolic disturbances by boosting blood sugar and fat storage. Living with a metabolic disorder often leads to psychological stress [87], driven by health concerns such as diabetic complications, restrictive lifestyle changes, and body image dissatisfaction. This chronic stress elevates levels of cortisol and catecholamines, which in turn promote maladaptive behaviors like overeating, disrupted sleep, and reduced physical activity. These behaviors exacerbate insulin resistance and contribute to further weight gain, reinforcing the cycle of metabolic dysfunction. Obesity, in particular, is strongly linked to poorer mental health outcomes, including depression and subclinical depressive symptoms. Although the relationship is bidirectional, evidence suggests that increased body weight more commonly leads to psychological distress rather than the reverse [88].

4. Prospects

The increasing recognition of chronic stress as a critical contributor to metabolic dysfunction has spurred a growing interest in uncovering its underlying mechanisms, improving early detection, and developing targeted therapeutic strategies. Future research directions are expected to focus on the integration of molecular, behavioral, and systemic approaches to prevent and manage stress-induced metabolic diseases.

A central area of investigation involves the dysregulation of the HPA axis and heightened SNS activity, both of which are implicated in the pathogenesis of conditions such as obesity, insulin resistance, and cardiovascular disease. Identifying reliable biomarkers, such as pro-inflammatory cytokines (e.g., interleukin-6), acute phase reactants (e.g., C-reactive protein), and cortisol secretion patterns, may enhance the early prediction and risk stratification of stress-related metabolic disorders [89]. Psychological stress influences caveolar function (which may contribute to metabolic syndrome and hyperuricemia [38,43])  in indirect yet significant ways through systemic pathways. As our understanding of the mind-body connection deepens, this area is becoming an increasingly important focus of research at the cellular level [90].

Emerging research on epigenetic modifications and mitochondrial dysfunction suggests that chronic stress may induce long-term changes in metabolic regulation, potentially predisposing individuals to disease later in life. In particular, epigenetic regulation of genes involved in glucose metabolism and mitochondrial efficiency could serve as a mechanistic link between psychological stress and metabolic impairment [91].

Given the interindividual variability in stress response, personalized medicine represents a promising frontier. Future studies may focus on resilience profiling by identifying genetic variants (e.g., GC receptor polymorphisms), behavioral traits, and environmental factors that confer protection against stress-induced metabolic disturbances. In this context, digital health technologies, such as wearable devices and mobile applications, offer innovative tools for real-time monitoring of stress indicators (e.g., heart rate variability, salivary cortisol) and delivering personalized, adaptive stress management strategies [92,93].

Psychological interventions such as cognitive-behavioral therapy (CBT) and mindfulness-based stress reduction have shown efficacy in attenuating stress-induced inflammation and improving metabolic outcomes [94,95]. These approaches hold promise for integration into both preventive and therapeutic frameworks.

Given that inflammation is estimated to mediate approximately 61.5% of the association between stress and metabolic syndrome [89], anti-inflammatory strategies warrant particular attention. Targeted therapies, including cytokine inhibitors (e.g., IL-1β antagonists), may be beneficial for individuals with prolonged exposure to psychosocial stress [96,97]. Nutritional interventions, such as diets rich in omega-3 fatty acids and polyphenols, can further mitigate oxidative stress and inflammation [98].

Socioeconomic and occupational stressors also play a significant role in the development of metabolic disorders. Future strategies should include workplace-level interventions, such as flexible scheduling and organizational stress reduction programs, aimed at lowering stress-related metabolic risk. In parallel, public health policies addressing broader social determinants, such as income inequality and neighborhood disadvantage, are critical to reducing chronic stress on a population level [99,100].

From a clinical perspective, a multidisciplinary and integrative approach is essential. Healthcare providers should routinely assess stress exposure in patients with metabolic disorders and incorporate stress management into treatment plans. This may involve combining pharmacologic interventions (e.g., β-blockers to reduce SNS overactivity) with lifestyle modifications [101], including exercise, nutritional guidance, and sleep hygiene.

Inclusively, the interplay between stress and metabolic health represents a vital area for ongoing scientific and clinical exploration. Advancing our understanding of biological pathways, enhancing personalized care, and enacting systemic changes are essential for addressing the rising burden of stress-induced metabolic diseases. With the support of emerging technologies and integrative healthcare models, more effective and sustainable strategies for prevention and treatment are on the horizon.

5. Conclusion

Chronic stress plays a critical role in metabolic dysfunction through sustained activation of the HPA axis and SNS, and indirectly through disruption of caveolae, leading to hormonal imbalances, inflammation, and insulin resistance. These physiological effects are intensified by unhealthy behaviors such as poor diet, inactivity, and sleep disruption. The relationship between stress and metabolic disorders is bidirectional, forming a self-perpetuating cycle reinforced by cellular dysfunction, gut dysbiosis, and epigenetic changes. Addressing this complex interaction requires a comprehensive approach, integrating early biomarker detection, psychological and pharmacologic therapies, and public health strategies targeting social and occupational stressors. Ultimately, interdisciplinary efforts are essential to disrupt this cycle and improve metabolic and mental health outcomes at both individual and societal levels.